Feb 17, 2025 | Case Study, Case Study Forecasting
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team at a large, multinational pharmaceutical company turned to Ozmosi to resolve the differences. Addressing the central questions required a...
Feb 17, 2025 | Business, Chronic Disease, Diabetes, Disease Area Trends
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human insulin Humalin and two premix offerings in analog Humalog® Mix 50/50 and human premix Humalin 75/25. Despite a legacy category, this portfolio...
Feb 17, 2025 | Case Study, Case Study Forecasting, Case Study Portfolio
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a newly acquired product. They needed to update and validate the current forecast models to identify the most effective development strategies...
Feb 17, 2025 | Case Study, Case Study Forecasting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding to establish a new organizational structure to better support children in the Philadelphia foster care system. The proposed structure was...
Feb 17, 2025 | Case Study, Market Scan
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy area within the Asia Pacific region. This overview had both internal and external perspectives covering the science, competitive and...
